期刊文献+

血管生成拟态与肿瘤微循环 被引量:8

Vasculogenic mimicry and microcirculation in tumors
下载PDF
导出
摘要 血管生成拟态(vasculogenic mimicry,VM)是近几年在少数高度恶性肿瘤中发现的一种独立于血管生成的全新肿瘤内微循环模式,即由恶性肿瘤细胞而非血管内皮细胞围成、细胞外基质界限的血管样结构.VM与肿瘤侵袭、转移及患者预后密切相关,其发生和肿瘤细胞呈现多潜能胚胎样表型及多种蛋白分子的生物学效应有关,肿瘤局部微环境也起着重要作用.现就VM的特点、发生机制及临床意义等研究进展作一综述. Vasculogenic mimicry (VM), a term that describes a novel form of angiogenesis-independent microcirculation pattern recently found in few highly aggressive tumors, is formed by tumor cells, rather than endothelial cells. VM is closely correlated with the invasiveness, metastasis and prognosis of related tumors. The presence of VM is associated with an embryonic like phenotype acquired by tumor cells and the biological effects of many proteins. Furthermore, tumor microenvironment also plays an important role in the development of VM. Here, we will review the advances in research on the characteristic, formative mechanisms and clinical significance of VM.
出处 《世界华人消化杂志》 CAS 北大核心 2009年第20期2015-2020,共6页 World Chinese Journal of Digestology
关键词 血管生成拟态 血管生成 肿瘤 微循环 Vasculogenic mimicry Angiogenesis Tumor Microcirculation
  • 相关文献

参考文献7

二级参考文献86

  • 1赵秀兰,杜静,张诗武,刘易欣,王欣,孙保存.肝细胞肝癌中血管生成拟态的研究[J].中华肝脏病杂志,2006,14(1):41-44. 被引量:42
  • 2郝静,王秀问,孙殿水,李蓓,蔡毅然.非小细胞肺癌中HIF-1α、GLUT1与COX-2表达的关系[J].临床与实验病理学杂志,2006,22(2):191-193. 被引量:3
  • 3Ohtsu A.Chemotherapy for metastatic gastric cancer:past,present,and future.J Gastroenterol 2008; 43:256-264 被引量:1
  • 4Demetri GD,von Mehren M,Blanke CD,Van den Abbeele AD,Eisenberg B,Roberts PJ,Heinrich MC,Tuveson DA,Singer S,Janicek M,Fletcher JA,Silverman SG,Silberman SL,Capdeville R,Kiese B,Peng B,Dimitrijevic S,Druker BJ,Corless C,Fletcher CD,Joensuu H.Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.N Engl J Med 2002; 347:472-480 被引量:1
  • 5Blanke CD,Demetri GD,von Mehren M,Heinrich MC,Eisenberg B,Fletcher JA,Corless CL,Fletcher CD,Roberts PJ,Heinz D,Wehre E,Nikolova Z,Joensuu H.Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.J Clin Oncol 2008; 26:620-625 被引量:1
  • 6Casali PG,Jost L,Reichardt P,Schlemmer M,Blay JY.Gastrointestinal stromal tumors:ESMO clinical recommendations for diagnosis,treatment and follow-up.Ann Oncol 2008; 19 Suppl 2:ii35-ii38 被引量:1
  • 7Demetri GD,van Oosterom AT,Garrett CR,Blackstein ME,Shah MH,Verweij J,McArthur G,Judson IR,Heinrich MC,Morgan JA,Desai J,Fletcher CD,George S,Bello CL,Huang X,Baum CM,Casali PG.Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib:a randomised controlled trial.Lancet 2006; 368:1329-1338 被引量:1
  • 8Vanhoefer U,Tewes M,Rojo F,Dirsch O,Schleucher N,Rosen O,Tillner J,Kovar A,Braun AH,Trarbach T,Seeber S,Harstrick A,Baselga J.Phase Ⅰ study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor.J Clin Oncol 2004; 22:175-184 被引量:1
  • 9Kim T.Technology evaluation:Matuzumab,Merck KGaA.Curr Opin Mol Ther 2004; 6:96-103 被引量:1
  • 10Dragovich T,McCoy S,Fenoglio-Preiser CM,Wang J,Benedetti JK,Baker AF,Hackett CB,Urba SG,Zaner KS,Blanke CD,Abbruzzese JL.Phase Ⅱ trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas:SWOG 0127.J Clin Oncol 2006; 24:4922-4927 被引量:1

共引文献193

同被引文献115

  • 1孙伟,范跃祖,张文忠,葛春燕,赵凤娣,周婷婷,宁艳霞.去甲斑蝥素对胆囊癌细胞体外模拟血管生成拟态的抑制作用[J].外科研究与新技术,2012,1(1):42-48. 被引量:5
  • 2彭民.阴茎包皮恶性黑色素瘤超声表现1例[J].中国超声诊断杂志,2006,7(12):902-902. 被引量:3
  • 3马成杰,李元青,李晓明,任映,宋崇顺,陈勃,黄晓琳,陈信义.三七活性成分抑制小鼠黑色素瘤生长的实验研究[J].亚太传统医药,2007,3(4):68-70. 被引量:1
  • 4The World Health Report 1997-conquering suffering, enriching humanity. World Health Forum 1997; 18:248-260. 被引量:1
  • 5Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83:18-29. 被引量:1
  • 6Goseki N, Koike M, Yoshida M. Histopathologic characteristics of early stage esophageal carcinoma. A comparative study with gastric carcinoma. Cancer 1992; 69:1088-1093. 被引量:1
  • 7Baylin SB. Mechanisms underlying epigeneticalIy mediated gene silencing in cancer. Semin Cancer Biol 2002; 12:331-337. 被引量:1
  • 8Mandard AM, Hainaut P, Hollstein M. Genetic steps in the development of squamous cell carcino- ma of the esophagus. Mutat Res 2000; 462:335-342. 被引量:1
  • 9Forastiere A, Weber R, Ang K. Treatment of head and neck cancer. N Engl J Med 2008; 358: 1076; au- thor reply 1077-1078. 被引量:1
  • 10Kihara C, Seki T, Furukawa Y, Yamana H, Kimura Y, van Schaardenburgh P, Hirata K, Nakamura Y. Mutations in zinc-binding domains of p53 as a prognostic marker of esophageal-cancer patients. ]pn J Cancer Res 2000; 91:190-198. 被引量:1

引证文献8

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部